Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

First NHS Trust has signed a contract to adopt Aiforia PD-L1 AI model for lung cancer in clinical diagnostics

Aiforia Technologies Plc, Press Release, 04 April 2023 at 15:30 a.m. EEST. The first NHS Trust of the PathLAKE Plus consortium has signed an individual contract to adopt Aiforia PD-L1 AI model for lung cancer in clinical diagnostics.The duration of the contract is three years, with a possible three-year extension. Aiforia previously announced in February  a contract award allowing 25 NHS Trusts of the PathLAKE Plus consortium to purchase Aiforia artificial intelligence solutions in the UK. This contract award enables Trusts

Head of Alma Consumer, Kari Kivelä and Senior Vice President, Human Resources, Virpi Juvonen will retire – Santtu Elsinen appointed new Head of Alma Consumer

Stock exchange release                        Changes in the management         4 April 2023 at 3.25 p.m. HEAD OF ALMA CONSUMER, KARI KIVELÄ AND SENIOR VICE PRESIDENT, HUMAN RESOURCES, VIRPI JUVONEN WILL RETIRE – SANTTU ELSINEN APPOINTED NEW HEAD OF ALMA CONSUMER  Head of Alma Consumer business segment Mr. Kari Kivelä (63) has announced that he will retire from his current post by the end of 2023, as made possible by his executive contract. Kivelä started as the publisher and corresponding editor-in-chief of Alma Media's tabloid Iltalehti in 2005 and has held his current position

Nicoya AB invests in KIANO LIFE AB, an e-commerce company focused on plant-based health products

The investment company Nicoya has acquired the majority of shares in KIANO. KIANO is an e-commerce company selling nutritional, plant-based, superfood mixes, protein powers and meal replacement powders. KIANO sells to a loyal customer base in Sweden and across Europe.KIANO was founded in 2020 with a strong founding team, of which three will remain as co-founders and actively working in the company following the investment. - We believe KIANO has all the fundamentals in place to scale quickly, with great products and expertise in D2C and performance marketing. The acquisition is bringing

Resolutions of the Annual General Meeting and the constitutive meeting of the Board of Directors of Pihlajalinna Plc

Pihlajalinna Plc                Stock exchange release                   4 April 2023 at 3:15 p.m.Resolutions of the Annual General Meeting and the constitutive meeting of the Board of Directors of Pihlajalinna PlcThe Annual General Meeting of Pihlajalinna Plc was held in Tampere on 4 April 2023. The meeting approved the company’s financial statements and the included consolidated financial statements for 2022, and discharged the members of the Board of Directors and the CEO who served during the 2022 financial year from liability. Dividend In accordance with the proposal of the

ScandiNova acquires majority share of IECO, adding power amplifiers and precision power supplies to its product line

Uppsala, Sweden, 4 April 2023. ScandiNova Systems AB, a leading provider of high-voltage pulsed power systems and magnets, today announced the acquisition of majority share of International Electric Company (IECO). IECO is a well-recognized producer of power amplifiers and precision power supplies for the global health care, scientific, and industrial markets. With this acquisition, ScandiNova aims to broaden its product offering, add key technology and increase knowledge and talent to meet future goals. "IECO is a perfect match with ScandiNova in terms of offering high-end

Camurus appoints Alberto Pedroncelli as Chief Medical Officer

Camurus appoints Alberto Pedroncelli as Chief Medical Officer Lund, Sweden — 4 April 2023 — Camurus AB (NASDAQ STO: CAMX) today announced the appointment of Alberto M. Pedroncelli, MD, PhD, as Chief Medical Officer and member of the company’s executive management team from 1 June 2023. Dr Perdoncelli is a leading global expert in clinical development and medical affairs within the field of endocrinology and oncology. He joins Camurus from a position as head of clinical development & medical affairs, global endocrinology at Recordati. Prior to this, he spent 12 years in different

Annual report and sustainability report 2022

Beijer Ref's Annual report and sustainability report for 2022 is now available for download on Beijer Ref's website www.beijerref.com. Printed copies of the annual report kan be ordered at the following email adress api@beijerref.com. Malmö, April 4, 2023 For more information, please contact: Christopher NorbyeCEOTelephone: +46 40-35 89 00Email: cne@beijerref.com Ulf BerghultCFOTelephone: +46 40-35 89 00Email: ubt@beijerref.com Niklas WillstrandGlobal Corporate Communications ManagerTelephone: +46 40-35 89 00Email: nwd@beijerref.com About Beijer Ref

Diamyd Medical partners with JDRF to advance the DIAGNODE-3 Phase 3 trial in Type 1 Diabetes

Diamyd Medical and JDRF, the leading global type 1 diabetes research and advocacy organization, have entered into a four-year research and development collaboration including a non-dilutive $5 million award to Diamyd Medical to support its ongoing Phase 3 trial with the precision medicine antigen-specific immunotherapy Diamyd[®]. The grant will be funded under JDRF’s Industry Discovery & Development Partnerships program that focuses on commercialization of therapeutics and devices for the treatment, cure, and prevention of type 1 diabetes and its complications. “We could not have a

Pampalo's gold production increased by 215 % compared to the corresponding period last year

Endomines Finland Plc's operational update for January-March 2023: Endomines Finland Plc, Stock Exchange Release, 4.4.2023, at 15.00 EETPampalo gold production in January-March 2023 increased by 215 % compared to the corresponding period in 2022. Production during Q1/2023 was 111.6 kg (35.4 kg) in kilograms, 3588 oz (1137 oz) in ounces.  In 2022, Endomines produced 267.5 kg, (equivalent to 8061 ounces) of gold.   During the first quarter of the year, production increased in line with the strategy announced by the company. Published production volumes are based on preliminary data,

Invitation to media and analyst briefing for Ericsson Q1 2023 report

· Report to be released at approximately 7:00 AM CEST on April 18, 2023 · One live video webcast for analysts, investors and journalists at 9:00 AM CESTEricsson's (NASDAQ: ERIC) financial report for the first quarter of 2023 will be published at approximately 7:00 AM CEST on April 18, 2023. The company will issue a press release with the complete financial report attached, including tables, in PDF format. Following publication of the press release, the financial report will be available on Ericsson's website: www.ericsson.com/en/investors/financial-reports/interim-reports

Notice to attend the Annual General Meeting of Elos Medtech AB (publ)

The shareholders of Elos Medtech AB (publ), corporate ID no. 556021-9650, headquartered in Gothenburg, are hereby invited to the annual general meeting (AGM) on Wednesday, 3 May 2023. The AGM will be held at 4:30 p.m. at Setterwalls Advokatbyrå, Sankt Eriksgatan 5, 411 05 Gothenburg, Sweden. The meeting venue will open at 3:30 p.m. for registration. Registration of participants at the meeting ends when the meeting is called to order. The Board of Directors has decided that the shareholders shall also be able to exercise their voting rights at the AGM by postal voting in accordance with the

NYAB Plc: Notice to the Annual General Meeting

NYAB PlcCOMPANY ANNOUNCEMENT04 April 2023 at 15:00NYAB Plc: Notice to the Annual General Meeting Shareholders of NYAB Plc (Business ID: 2393685-6) are hereby summoned to the Annual General Meeting that will be held on Wednesday, 26 April 2023, at 14:30 Finnish time. The location of the meeting will be Clarion Hotel at Tyynenmerenkatu 2, Helsinki. A. MATTERS ON THE AGENDA OF THE ANNUAL GENERAL MEETING The following matters will be on the agenda of the Annual General Meeting: 1. Opening of the meeting 2. Calling the meeting to order 3. Election of persons to scrutinize

Dogecoin Price Prediction as DOGE Spikes 30% After Musk Changes Twitter Logo - Love Hate Inu Next to Pump?

Dogecoin is in the news again after Elon Musk’s latest publicity stunt prompted the coin’s price to rocket by over 30% in less than four hours. Musk opted to change Twitter's logo to the symbol of Dogecoin, which sparked colossal attention from social media and mainstream media channels. However, many investors are now hoping that the positive contagion effect from this event spreads to other coins and tokens – with Love Hate Inu being one project poised to benefit hugely.Musk Seeks Lawsuit Dismissal by Leveraging Twitter’s Power Elon Musk is constantly in the limelight for both

Sitowise Group Plc - Managers' Transactions - Haasmaa

Sitowise Group Plc                    Managers' transactions           4 April 2023 at 2.30 pm EET ____________________________________________ Person subject to the notification requirement Name: Heikki Haasmaa Position: Chief Executive Officer  Issuer: Sitowise Group Oyj LEI: 743700HOHMOHAANHFF73 Notification type: INITIAL NOTIFICATION Reference number: 28354/7/17 ____________________________________________ Transaction date: 2023-03-31 Venue: NASDAQ HELSINKI LTD (XHEL) Instrument type: SHARE ISIN: FI4000480215 Nature of transaction: ACQUISITION

Troax Group AB publishes Annual Report for 2022

Hillerstorp April 4, 2023, 13:30 CETTroax Group AB's Annual Report for 2022 is now available in English on www.troax.com.A PDF version is enclosed to this press release. The Group’s Sustainability Report for 2022 is also available on the website. For additional information, please contact:  Thomas WidstrandPresident and CEOTroax Group ABBox 89335 04 HillerstorpTel +46 (0)370-828 31thomas.widstrand@troax.com This information is information that Troax Group AB is obliged to make public pursuant to the Securities Markets Act (2007:528). The information was submitted

Notice of annual general meeting in AB Sagax (publ)

The shareholders of AB Sagax (publ), 556520-0028, (the ”Company”) are hereby invited to the Annual General Meeting (“AGM”) to be held on Tuesday 9 May 2023 at 4.00 p.m. at Nalen, David Bagares gata 17, in Stockholm. The Board of Directors has resolved that shareholders shall have the right to exercise their voting rights in advance through postal voting pursuant to § 9 in the Company’s Articles of Association. Consequently, shareholders may choose to exercise their voting rights at the AGM by attending by postal voting, in person, or through a proxy. Participation by postal voting

NYAB Plc: Proposals of the Shareholders' Nomination Board to the Annual General Meeting

NYAB PlcCOMPANY ANNOUNCEMENT04 April 2023 at 14:30NYAB Plc: Proposals of the Shareholders’ Nomination Board to the Annual General Meeting NYAB Plc’s Shareholders’ Nomination Board has submitted proposals for the Annual General Meeting to be held on 26 April 2023 regarding the composition and remuneration of the Board of Directors. Nomination Board proposes that nine members would be elected to the Board of Directors. According to the proposal, current members Markku Kankaala, Johan K Nilsson, Johan Larsson, Mikael Ritola, Jari Suominen, and Lars-Eric Aaro would be re-elected as

Strong premiere for Executive Insights in Stockholm

How should life science companies capture investors’ interest in a difficult financial environment? What is important to consider when it comes to the company’s brand? How to succeed with partnering? These were some of the topics during the premiere of Executive Insights at the World Trade Center in Stockholm.Read the article about Expert Insights in Stockholm at biostock.se: https://www.biostock.se/en/2023/04/strong-premiere-for-executive-insights-in-stockholm/ This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/en/

Notice of the AGM of Beijer Electronics Group AB

The shareholders of Beijer Electronics Group AB (publ) are hereby convened to the Annual General Meeting (AGM), which will be held on Wednesday, May 10, 2023, at 15:00 CEST at Scandic Triangeln, Malmö. Registration opens at 14:00 CEST. The Board of Directors has decided that the shareholders shall also be able to exercise their voting rights by postal voting in accordance with the rules of the Articles of Association. It will also be possible to follow the Annual General Meeting online, on www.beijergroup.com, but without the opportunity to vote or ask questions. No special registration is

NOTICE OF ANNUAL GENERAL MEETING IN BALCO GROUP AB

April 4, 2023The shareholders in Balco Group AB, reg. no. 556821-2319, are invited to the Annual General Meeting, to be held on Tuesday, May 9, 2023, at 3.00 pm at Kök 11, Honnörsgatan 15 in Växjö. Registration starts at 2.30 pm.   The Board of Directors has, pursuant to Chapter 7, Section 4 a of the Swedish Companies Act (Sw. aktiebolagslagen) and the company's Articles of Association, decided that shareholders shall be able to exercise their voting rights by postal voting before the General Meeting. Consequently, shareholders may choose to exercise their voting rights at the AGM by

Ework Group publishes Annual and Sustainability report 2022

Hereby, Ework Group AB (publ) publishes the Annual and Sustainability report 2022.The full annual report is available in the attached pdf and can also be downloaded from the company's website, www.eworkgroup.com.    For further information, please contact:Klas Rewelj, CFO, Ework GroupPhone: +46 (0)70 626 54 24, e-mail: klas.rewelj@eworkgroup.com Cathrin Wisén, Communications Manager, Ework GroupPhone: +46 (0)72 123 51 20, e-mail: cathrin.wisen@eworkgroup.com This information is information that Ework Group AB is obliged to make public pursuant to the Securities Market Act.

Gedea Biotech awarded SEK 3M from SWElife and MedTech4Health for groundbreaking antibiotic free women’s health trial

Impact on microbiome could be key to preventing vulvovaginal infection recurrence Lund, Sweden, April 4, 2023: Gedea Biotech today announced it has been awarded SEK 3M grant from the Swedish innovation programs, SWElife and MedTech4Health in a collaboration with Danderyd hospital, Huddinge hospital and Karolinska Institute, to fund a further clinical trial of its antibiotic free treatment pHyph for the treatment of vulvovaginal candida infections (VVC).Vaginal infections affect at least 400 million women worldwide every year, but with current treatments, the risk of recurrence is

Leading Australian insurance group DKG launches new dynamic insurance offer for fleets using Greater Than’s AI technology

· With over 50 years of experience, DKG Group (DKG) is one of Australia’s only providers of behavior-based insurance combined with claims management solutions. · DKG will launch Fuse Fleet, a dynamic insurance solution that rewards safe driving and enables accurate pricing of premiums. · Fuse Fleet will utilize Greater Than’s unique pattern AI technology to convert GPS data into crash probability insights. Greater Than (GREAT: ST), the global provider of driver crash probability and climate impact intelligence, today announced a partnership with DKG, one of Australia's leading

Supreme Court to hear appeal by Artic Mineral Resources

Reference is made to the stock exchange notice from Nordic Mining ASA (“Nordic Mining” or the “Company”) on 30 November 2022 relating to the appeal by Artic Mineral Resources (“AMR”) on the ruling from the Borgarting Court of Appeal. The Supreme Court's appeals committee has today informed that the appeal in the case between AMR and Nordic Rutile AS (“NRU”) will be heard before the Supreme Court. The hearing is tentatively scheduled to take place before the summer 2023. The Oslo District Court and the Borgarting Court of Appeal both ruled in favour of NRU and concluded that AMR shall

There are no items matching the current filter
There are no more items matching the current filter
Back to top